Pfizer Share Price
Small Cap | Pharmaceuticals and health care | NSE: PFIZER | BSE: 500680
₹4,094.55 
-18.05 (-0.44 %)
Last Updated: 21 Feb 2025 04:01 PM
BEARISH
Overview
Open (₹) 4,077.75
High (₹) 4,178.90
Low (₹) 4,077.75
Prev. Close (₹) 4,112.60
Volume 1,532
VWAP (₹) 4,107.58
ROCE (%) 20.46
Industry P/E 43.99
TTM P/E 30.43
P/B Ratio 5.21
Market Cap (₹) Cr.18,734.15
Dividend Yield (%)0.85
EPS (₹) 120.51
ROE15.33%
Sales Growth (%) -9.55
Profit Growth (%)-11.64
Day Range
4,178.904,178.90
52 Week Range
4,012.656,452.85
Historical Returns
Returns (6M)
-29.33 %
Returns (1Y)
-8.11 %
Returns (3Y)
-4.46 %
Returns (5Y)
-1.57 %
Returns (6M)
-29.33 %
Returns (1Y)
-8.11 %
Returns (3Y)
-4.46 %
Returns (5Y)
-1.57 %
SWOT Analysis
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
Technicals
Technical Rating
BEARISHRSI 24.65
MFI 39.02
ATR 141.18
Commodity Channel Index -81.76
ROC125 -29.99
ROC21 -13.08
Williams %R -86.06
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 4,156.39 | 4,218.22 | 4,257.54 | 4,117.07 | 4,055.24 | 4,015.92 | 3,954.09 |
| Week Ago | 4,253.36 | 4,337.53 | 4,433.06 | 4,157.83 | 4,073.66 | 3,978.13 | 3,893.96 |
| Month Ago | 4,992.25 | 5,030.35 | 5,074.60 | 4,948.00 | 4,909.90 | 4,865.65 | 4,827.55 |
EMA & SMA
4094.55
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 4138.50
9 Day 4128.25
10 Day 4163.76
12 Day 4227.36
14 Day 4244.48
20 Day 4314.60
26 Day 4454.48
50 Day 4744.05
100 Day 5067.97
200 Day 5123.18
Deals & Announcements
Bulk and Block Deals
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 04 May, 2020 | Anil Gupta | Acquisition | ₹4,200.00 | 25 | BSE |
| 04 May, 2020 | Anil Gupta | Acquisition | ₹4,050.00 | 100 | BSE |
| 04 May, 2020 | Anil Gupta | Disposal | ₹4,393.333333333333333333333333 | 150 | BSE |
| 04 May, 2020 | Anil Gupta | Acquisition | ₹4,078.04 | 25 | BSE |
| 04 May, 2020 | Anil Gupta | Acquisition | ₹4,116.00 | 125 | BSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 17 May, 2024 | Rs.35.0000 per share(350%)Final Dividend | 21 Aug, 2024 | 21 Aug, 2024 |
| 16 May, 2023 | Rs.5.0000 per share(50%)Special Dividend | 11 Aug, 2023 | 11 Aug, 2023 |
| 15 May, 2023 | Rs.35.0000 per share(350%)Final Dividend | 11 Aug, 2023 | 11 Aug, 2023 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 21 Feb, 2025 | BSE India | Pursuant to the Regulation 30 of the Listing Regulations, we hereby inform that, the Board of Directors of the Company at their Meeting held today, that commenced on February 20, 2025 at 11.00 a.m. and concluded on February 21, 2025 at 1.45 p.m have approved a proposal today, to enter into a Marketing and Supply Agreement with Mylan Pharmaceuticals Private Limited for Marketing and Sale of two brands of the Company, viz., Ativan and Pacitane. |
| 14 Feb, 2025 | NSE India | PFIZER LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
| 14 Feb, 2025 | NSE India | Intimation regarding completion of term of Independent Directorship of Mr. Sunil Lalbhai |
| 14 Feb, 2025 | BSE India | Intimation regarding completion of term of Independent Directorship of Mr. Sunil Lalbhai |
| 05 Feb, 2025 | NSE India | Receipt of GST Order Levying Tax Demand and Penalty |
| 05 Feb, 2025 | BSE India | Receipt of GST Order Levying Tax Demand and Penalty |
| 05 Feb, 2025 | NSE India | Receipt Of GST Order Levying Tax Demand and Penalty |
| 05 Feb, 2025 | BSE India | Receipt of GST Order levying tax demand and penalty |
| 04 Feb, 2025 | NSE India | Receipt of GST Order for a Tax Demand, Interest and Penalty |
| 04 Feb, 2025 | BSE India | Receipt of GST Order for a tax demand, interest and penalty |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 28 Jan, 2025 | 31 Jan, 2025 |
| Quarterly Results | -- | 22 Oct, 2024 | 28 Oct, 2024 |
| Quarterly Results | -- | 23 Jul, 2024 | 29 Jul, 2024 |
| Audited Results & Final Dividend | -- | 07 May, 2024 | 17 May, 2024 |
| Quarterly Results | -- | 01 Feb, 2024 | 09 Feb, 2024 |
| Quarterly Results | -- | 19 Oct, 2023 | 28 Oct, 2023 |
| Quarterly Results | -- | 07 Aug, 2023 | 11 Aug, 2023 |
| Audited Results & Final Dividend | -- | 08 May, 2023 | 15 May, 2023 |
| Quarterly Results | -- | 03 Feb, 2023 | 09 Feb, 2023 |
| Quarterly Results | -- | 04 Nov, 2022 | 11 Nov, 2022 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Pfizer
Pfizer is a Public Limited Listed company incorporated on 21/11/1950 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24231MH1950PLC008311 and registration number is 008311. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 2193.17 Cr. and Equity Capital is Rs. 45.75 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
MNC Associate
Founded
1950
Managing Director
Ms. Meenakshi Nevatia
NSE Symbol
PFIZER
Pfizer Management
| Name | Designation |
|---|---|
| Mr. Pradip Shah | Chairman & Ind.Director |
| Ms. Meenakshi Nevatia | Managing Director |
| Mr. P Rengan | Executive Director - Operations |
| Mr. Amit Agarwal | Executive Director & CFO |
| Mr. Sunil Lalbhai | Independent Director |
| Mr. Uday Khanna | Independent Director |
| Ms. Meena Ganesh | Independent Director |
| Mr. Lakshmanan Krishnakumar | Independent Director |
| Ms. Sonia Singh | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| SunPhrmInds | ₹4,46,576.22 | ₹1,643.75  ₹1,669.30(-1.53%) | ₹1,249.800 - ₹1,960.200 |
| Divis Labora | ₹1,56,123.40 | ₹5,757.05 ₹5,978.30(-3.70%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,21,675.13 | ₹1,475.75 ₹1,479.70(-0.27%) | ₹1,240.700 - ₹1,702.000 |
| ManKind Phar | ₹1,18,478.90 | ₹2,327.75 ₹2,348.45(-0.88%) | ₹1,910.100 - ₹3,050.000 |
| DrReddysLab | ₹1,15,939.04 | ₹1,151.80 ₹1,170.95(-1.64%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Pfizer
What is the share price of Pfizer?
The share price of Pfizer on 21 Feb, 2025 is ₹ 4,094.55.
What is 52W high and 52W low share price of Pfizer?
The highest and lowest 52W share prices of Pfizer are ₹ 6452.850 and ₹ 4050.100
What is the market cap of Pfizer?
The market capitalization of Pfizer as of 21 Feb, 2025 is ₹ 18,734.15 Crores
What is the P/E ratio of Pfizer?
The current P/E ratio of Pfizer as of 21 Feb, 2025 is 43.99
What is the PB ratio of Pfizer?
The PB ratio of Pfizer as of 21 Feb, 2025 is 5.21
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)